CA2010177A1 - Allergene d'acarien purifie - Google Patents

Allergene d'acarien purifie

Info

Publication number
CA2010177A1
CA2010177A1 CA2010177A CA2010177A CA2010177A1 CA 2010177 A1 CA2010177 A1 CA 2010177A1 CA 2010177 A CA2010177 A CA 2010177A CA 2010177 A CA2010177 A CA 2010177A CA 2010177 A1 CA2010177 A1 CA 2010177A1
Authority
CA
Canada
Prior art keywords
purified mite
mites
sugar
culture
contained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2010177A
Other languages
English (en)
Other versions
CA2010177C (fr
Inventor
Satoru Oka
Kazuhisa Ono
Seiko Shigeta
Takeshi Wada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fumakilla Ltd
Hiroshima University NUC
Original Assignee
Fumakilla Ltd
Hiroshima University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fumakilla Ltd, Hiroshima University NUC filed Critical Fumakilla Ltd
Publication of CA2010177A1 publication Critical patent/CA2010177A1/fr
Application granted granted Critical
Publication of CA2010177C publication Critical patent/CA2010177C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002010177A 1989-08-24 1990-02-15 Allergene d'acarien purifie Expired - Lifetime CA2010177C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1220064A JP2787162B2 (ja) 1989-08-24 1989-08-24 精製ダニアレルゲン
JP220064/1989 1989-08-24

Publications (2)

Publication Number Publication Date
CA2010177A1 true CA2010177A1 (fr) 1991-02-24
CA2010177C CA2010177C (fr) 2000-03-14

Family

ID=16745373

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002010177A Expired - Lifetime CA2010177C (fr) 1989-08-24 1990-02-15 Allergene d'acarien purifie

Country Status (4)

Country Link
US (2) US5496554A (fr)
JP (1) JP2787162B2 (fr)
AU (1) AU632538B2 (fr)
CA (1) CA2010177C (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0503505B1 (fr) * 1991-03-09 1995-09-06 Fumakilla Limited Allergène d'ararien purifié
AU2011260233B2 (en) * 2010-06-03 2014-09-18 Alk-Abello A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
RU2711727C1 (ru) * 2010-06-03 2020-01-21 Альк-Абелло А/С Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей и способ его получения

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5433948A (en) * 1990-02-13 1995-07-18 Thomas; Wayne R. Cloning and sequencing of allergens of dermatophagoides (house dust mite)
DE69131131T2 (de) * 1990-09-11 1999-10-14 Institute For Child Health Research Klonierung und sequenzierung von dermatophagoiden-antigenen (hausstaubmilben)
US7288256B1 (en) 1991-10-16 2007-10-30 Merck Patent Gmbh T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US5968526A (en) * 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
AU743647B2 (en) * 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
US7128921B1 (en) * 1998-04-17 2006-10-31 Heska Corporation Dermatophagoides proteins and fragments thereof
US6455686B1 (en) * 1998-04-17 2002-09-24 Heska Corporation Dermatophagoides nucleic acid molecules, proteins and uses thereof
AU1951001A (en) * 2000-04-06 2001-09-17 Panacea Pharm Llc Microbial delivery system
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
JP4852738B2 (ja) * 2005-02-08 2012-01-11 国立大学法人広島大学 スギ花粉由来の新規タンパク質およびそのタンパク質をコードする遺伝子並びにそれらの利用
RU2331437C1 (ru) * 2007-01-09 2008-08-20 Государственное учреждение Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова Российской академии медицинских наук Способ получения аллергена из клещей домашней пыли рода дерматофагоидес
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
AU2014277697B2 (en) * 2010-06-03 2016-06-16 Alk-Abelló A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0503505B1 (fr) * 1991-03-09 1995-09-06 Fumakilla Limited Allergène d'ararien purifié
AU2011260233B2 (en) * 2010-06-03 2014-09-18 Alk-Abello A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
AU2011260233C1 (en) * 2010-06-03 2015-04-16 Alk-Abello A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
US9259464B2 (en) 2010-06-03 2016-02-16 Alk-Abelló A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
US9265824B2 (en) 2010-06-03 2016-02-23 Alk-Abello A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
RU2710544C2 (ru) * 2010-06-03 2019-12-27 Альк-Абелло А/С Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей, и способ его получения
RU2711727C1 (ru) * 2010-06-03 2020-01-21 Альк-Абелло А/С Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей и способ его получения
US10842866B2 (en) 2010-06-03 2020-11-24 Alk-Abelló A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
US10874736B2 (en) 2010-06-03 2020-12-29 Alk-Abello A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof

Also Published As

Publication number Publication date
US5496554A (en) 1996-03-05
JPH0381300A (ja) 1991-04-05
US5773010A (en) 1998-06-30
AU5059890A (en) 1991-02-28
AU632538B2 (en) 1993-01-07
CA2010177C (fr) 2000-03-14
JP2787162B2 (ja) 1998-08-13

Similar Documents

Publication Publication Date Title
CA2010177A1 (fr) Allergene d'acarien purifie
EP0384288A3 (fr) Dérivés de pipéridine, leur préparation et leur utilisation
CA2000786A1 (fr) 3-piperidinyl-1,2-benzisoxazoles
AU1466388A (en) Low molecular weight heparins of regular structure, their preparation and their biological uses
IL93508A0 (en) Novel benzimidazole and azabenimidazole derivatives,their methods of preparation,synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers
ATE142691T1 (de) Proteine mit faktor-viii-aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende pharmazeutische zusammensetzungen
IL93433A0 (en) Pyrrole derivatives,their preparation and pharmaceutical compositions containing them
CA2169834A1 (fr) Formulations pharmaceutiques du facteur de croissance nerveuse
CA2193993A1 (fr) Nouvelles proteines mutantes de l'il-4 humaine utilisees comme antagonistes ou agonistes partiels de l'interleukine humaine 4
EP0393493A3 (fr) Dérivés de acides biliaires fluorinés, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0400522A3 (fr) Procédé pour la préparation des particules micronisées biodégradables
ATE67212T1 (de) Thiazolidin-4-carbonsaeurederivat, seine herstellung und pharmazeutische zusammensetzungen, die dieses enthalten.
DE69333412D1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
CA2071907A1 (fr) Proteines bcrf1 utilisees comme inhibiteurs de l'interferon-a
DE3781627D1 (de) Indanderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, diese enthaltende pharmazeutische zusammensetzungen und erhaltene zwischenprodukte.
CA2020346A1 (fr) Facteurs a1, a2, a3 et h de l'antibiotique ge 2270
CA2047802A1 (fr) Compositions pharmaceutiques
EP0354568A3 (fr) Dérivés du catéchol
EP0402923A3 (fr) 2,5-Diamino-tétralines, leur procédé de préparation et leur utilisation comme médicament
FR2608159B1 (fr) Nouveaux derives de l'acide furannuronique, leur preparation et leur utilisation comme medicaments
IT1234230B (it) Solfonammidi di benzilidene canfora derivanti da amminoacidi e loro impiego in cosmesi particolarmente come filtri solari
FR2636531B1 (fr) Nouveaux derives de benzylidene-cyclanones, leur procede de preparation, leur utilisation en tant qu'agents antioxydants et comme filtres solaires, compositions cosmetiques et pharmaceutiques les contenant
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
DE3770726D1 (de) Decahydrochinolinderivate, verfahren zu ihrer herstellung und zwischenprodukte davon, ihre verwendung als arzneimittel und ihre pharmazeutischen zusammensetzungen.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry